/FTXH
FTXH Stock - First Trust Nasdaq Pharmaceuticals ETF
Financial Services|Asset ManagementNASDAQ
$33.02+1.68%
+$0.55 (+1.68%) • Dec 19
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.86
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.95
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $36.32
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FTXH
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$32.69 – $33.35
TARGET (TP)$37.97
STOP LOSS$30.37
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.62
52W High$33.36
52W Low$23.29
Avg VolumeN/A
Income Statement (Fiscal Year)
Loading financial data...
Company Overview
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
Loading analyst ratings...
Earnings History & Surprises
FTXHLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about FTXH
What is FTXH's current stock price?
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is currently trading at $33.02 per share. The stock has moved +1.68% today.
What is the analyst price target for FTXH?
No analyst price targets are currently available for this stock.
What sector is First Trust Nasdaq Pharmaceuticals ETF in?
First Trust Nasdaq Pharmaceuticals ETF operates in the Financial Services sector, specifically within the Asset Management industry. The company is traded on the NASDAQ exchange.
What is FTXH's market cap?
First Trust Nasdaq Pharmaceuticals ETF has a market capitalization of $0.02 billion, making it a small-cap company.
Does FTXH pay dividends?
No, First Trust Nasdaq Pharmaceuticals ETF does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorFTXG
First Trust Nasdaq Food & Beverage ETF
$21.27
Mkt Cap: $0.0B
HECA
Hedgeye Capital Allocation ETF
$28.17
Mkt Cap: $0.0B
JCHI
J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Active China ETF
$55.13
Mkt Cap: $0.0B
LST
Managed Portfolio Series Leuthold Select Industries ETF
$40.38
Mkt Cap: $0.0B
OVS
Overlay Shares Small Cap Equity ETF
$36.70
Mkt Cap: $0.0B
PEMX
Putnam Emerging Markets Ex-China ETF
$62.48
Mkt Cap: $0.0B
RAYJ
Rayliant SMDAM Japan Equity ETF
$33.55
Mkt Cap: $0.0B
RNEM
First Trust Emerging Markets Equity Select ETF
$55.40
Mkt Cap: $0.0B
SCAP
Infrastructure Capital Small Cap Income ETF
$36.54
Mkt Cap: $0.0B
UPW
ProShares Ultra Utilities
$21.43
Mkt Cap: $0.0B
Explore stocks similar to FTXH for comparison